Comparative Evaluation of Traditional Susceptibility Testing for MRSA with the PCR Approach
- 1 Bio Products Laboratory, Elstree, UK
- 2 Science Research Center, Karaganda State Medical University, Karaganda, Kazakhstan
- 3 Science Research Center, Karaganda State Medical University, Karaganda, Kazakhstan
- 4 Science Research Center, Karaganda State Medical University, Karaganda, Kazakhstan
- 5 Faculty of Medicine, Transilvania University of Brasov, Brasov, Romania
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a multi-drug resistant pathogen, which is responsible for increasing cases of serious diseases, including life-threatening diseases and nosocomial and community-acquired infections. Laboratory identification of MRSA is crucial and essential both for initiation of appropriate antimicrobial therapies and for effective infection control strategies that are designed to limit the spread of MRSA. In spite of the availability of commercial kits for MRSA detection in the market, the Clinical and Laboratory Standards Institute (CLSI) recommends the use of phenotypic methods, such as the disk diffusion method with oxacillin or with cefoxitin, as well as a serial dilution method with oxacillin. Nevertheless, some studies have shown that results obtained with such phenotypic methods are controversial. The aim of the study described in this paper was to comparatively evaluate the traditional susceptibility testing for MRSA with PCR as the gold standard assay. Analysis of collection (n = 68) isolates of Staphylococcus aureus revealed that the serial dilution method with oxacillin possessed the highest sensitivity (at 100%). In contrast, the disk diffusion methods with oxacillin and cefoxitin showed lower sensitivity (95.83%, 95% CI (78.81%-99.30%)). Furthermore, the borderline value of zone inhibition diameters for cefoxitin might be considered as a risk, and they may give false-susceptible result.
- Yi, J.Y. and Kim, E.C. (2010) Microbiological Characteristics of Methicillin-Resistant Staphylococcus aureus. Korean Journal of Clinical Microbiology, 13, 1-6. http://dx.doi.org/10.5145/KJCM.2010.13.1.1
- Cosgrove, S.E., et al. (2003) Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-Analysis. Clinical Infectious Diseases, 36, 53-59. http://dx.doi.org/10.1086/345476
- Chambers, H.F. (2005) Community-Associated MRSA—Resistance and Virulence Converge. The New England Journal of Medicine, 352, 1485-1487. http://dx.doi.org/10.1056/NEJMe058023
- Honda, H., Krauss, M.J., Coopersmith, C.M., Kollef, M.H., Richmond, A.M., Fraser, V.J. and Warren, D.K. (2010) Staphylococcus aureus Nasal Colonization and Subsequent Infection in Intensive Care Unit Patients: Does Methicillin Resistance Matter? Infection Control and Hospital Epidemiology, 31, 584-591. http://dx.doi.org/10.1086/652530
- Hiramatsu, K., Cui, L.Z., Kuroda, M. and Ito, T. (2001) The Emergence and Evolution of Methicillin-Resistant Staphylococcus aureus. Trends in Microbiology, 9, 486-493. http://dx.doi.org/10.1016/S0966-842X(01)02175-8
- Labrou, M., Michaila, G., Ntokoua, E., Pittarasb, T.E., Pournarasa, S. and Tsakris, A. (2012) Activity of Oxacillin versus That of Vancomycin against Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates Evaluated by Population Analyses, Time-Kill Assays, and a Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy, 56, 3388-3391. http://dx.doi.org/10.1128/AAC.00103-12
- Saeed, K., Dryden, M. and Parnaby, R. (2010) Oxacillin-Susceptible MRSA, the Emerging MRSA Clone in the UK? Journal of Hospital Infection, 76, 267-268. http://dx.doi.org/10.1016/j.jhin.2010.03.004
- Velasco, D., Tomas, M., Cartelle, M., Beceiro, A., Perez, A., Molina, F., Moure, R., Villanueva, R. and Bou, G. (2005) Evaluation of Different Methods for Detecting Methicillin (Oxacillin) Resistance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 55, 379-382. http://dx.doi.org/10.1093/jac/dki017
- CLSI (2013) Performance Standards for Antimicrobial Susceptibility Testing; CLSI Approved Standard M100-S23. Clinical and Laboratory Standards Institute, Wayne.
- CLSI (2009) Performance Standards for Antimicrobial Susceptibility Testing M100-S19; Nineteenth Informational Supplement. Vol. 29, Clinical and Laboratory Standards Institute, Wayne.